| 1 |
31317804 | Bergamottin can be used to assess CYP3A-mediated intestinal first-pass metabolism without affecting P-glycoprotein-mediated efflux in rats. | 2020 Apr |
1 |
| 2 |
32078103 | Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats. | 2020 Jun |
1 |
| 3 |
30537097 | Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D3 : Effects on in vivo oral absorption and disposition of buspirone in rats. | 2019 May |
5 |
| 4 |
25574821 | Pinelliae rhizoma, a toxic chinese herb, can significantly inhibit CYP3A activity in rats. | 2015 Jan 7 |
1 |
| 5 |
27013798 | Modulation of Hepatic Cytochrome P450 Enzymes by Curcumin and its Pharmacokinetic Consequences in Sprague-dawley Rats. | 2015 Oct |
1 |
| 6 |
24710899 | In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism. | 2014 May |
1 |
| 7 |
25434398 | The influences of aconitine, an active/toxic alkaloid from aconitum, on the oral pharmacokinetics of CYP3A probe drug buspirone in rats. | 2014 |
4 |
| 8 |
23085095 | The exposure of highly toxic aconitine does not significantly impact the activity and expression of cytochrome P450 3A in rats determined by a novel ultra performance liquid chromatography-tandem mass spectrometric method of a specific probe buspirone. | 2013 Jan |
1 |
| 9 |
23873286 | Assessment of CYP3A-mediated drug-drug interaction potential for victim drugs using an in vivo rat model. | 2013 Oct |
1 |